Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial

NCT04342650 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT04342650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04342650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Phase 2
Overall status
Completed
Start date
April 8, 2020
Completion date
June 8, 2020
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical trial, covid-19, sars-cov infection, severe acute respiratory syndrome (sars) pneumonia